Decibel Therapeutics : Acquisition/Asset Disposal - Form 8-K

Item 2.01.

Completion of Acquisition or Disposition of Assets

As described in the Introductory Note above, on September 25, 2023, Purchaser irrevocably accepted for payment all shares of Common Stock validly tendered and not validly withdrawn pursuant to the Offer on or prior to the Expiration Time. On September 25, 2023, the Merger was completed pursuant to Section 251(h) of the DGCL, with no vote of the Company's stockholders required. Upon the consummation of the Merger, the Company became a wholly owned subsidiary of Parent.

The information set forth in the Introductory Note of this Current Report on Form 8-Kis incorporated by reference into this Item 2.01.